Quijano, Asher Edrian .

HRN: 21-15-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
CEFTAZIDIME 1GM (VIAL)
05/14/2022
05/20/2022
IV
175
Q12hrs
Pcap C
Waiting Final Action 
05/15/2022
MUPIROCIN 2%, 15G (TUBE)
05/15/2022
05/21/2022
TOPICAL
2% Ointment
2x A Day For 7 Days
IV Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: